The Endometrial Ablation Market was valued at USD 3.2 Billion in 2022 and is expected to grow with a CAGR of 7.3% from 2023 to 2033. Increasing awareness about women’s health and endometrial ablation, the surge in demand for minimally invasive procedures, and the rising prevalence of menorrhagia are some of the factors that are expected to drive the endometrial ablation market during the forecast period. The market accounted for an absolute dollar opportunity of nearly USD 3.4 Billion from 2023 to 2033.
| Attribute | Details |
|---|---|
| Global Endometrial Ablation Market (2023) | USD 3.4 Billion |
| Global Endometrial Ablation Market (2033) | USD 6.8 Billion |
| Global Endometrial Ablation Market CAGR (2023 to 2033) | 7.3% |
| USA Endometrial Ablation Market CAGR (2023 to 2033) | 6.3% |
| Key Companies Profiled | Medtronic; CooperSurgical Inc.; Boston Scientific Corp.; Ethicon, Inc.; Olympus Corp.; Richard Wolf GmbH; AngioDynamics; Hologic, Inc.; Minerva Surgical, Inc. |
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
As per the Endometrial Ablation Market industry research by Future Market Insights - a market research and competitive intelligence provider, historically, from 2018 to 2022, the market value increased at around a CAGR of 5.9%. Growing with an absolute dollar opportunity of USD 3.4 Billion from 2023 to 2033, the market is projected to reach USD 6.8 Billion by 2033.
With the advent of minimally invasive endometrial ablation treatments, the endometrium can be destroyed in a more expedient, outpatient setting. This operation is less dangerous and technically straightforward to carry out.
The International Federation of Gynaecology and Obstetrics estimates that between 3% and 30% of reproductive-aged women are affected by Abnormal Uterine Bleeding. Women's treatment plans have become the key focus of the general health industry in the modern world. Governments and private organizations around the world have placed women's health at the center of their wellbeing race.
In India, such as in many other locations, women are eligible for several tax benefits and exemptions under the provisions of several sections of the tax code. Women's healthcare initiatives may promote the effectiveness of treatment alternatives, which will boost the market.
Principal Consultant
Asia Pacific has high women population, which makes it a lucrative destination for endometrial ablation. Growing health infrastructure and awareness about new women’s healthcare technologies are further expected to swell the demand for endometrial ablation procedures in the region. Furthermore, the market is expected to develop due to an increase in the prevalence of menorrhagia. In the past years, the availability of ambulatory surgery centers and improved endometrial ablation devices in clinics are driving the regional demand.
The market in the USA is expected to reach a valuation of USD 1.8 Billion by 2033. Between 2023 and 2033, the market is expected to expand by USD 807.5 Million in absolute dollars.
The market in the United kingdom is expected to reach a valuation of USD 319.8 Million by 2033. Growing with a CAGR of 8.4% in the forecast period, the market in the country is projected to garner an absolute dollar opportunity of around USD 176 Million.
In Japan, the market is expected to grow at a CAGR of 9.2% from 2023 to 2033, reaching around USD 360 Million by 2033. The market in the country is expected to gross an absolute dollar opportunity of USD 210 Million during the forecast period.
The market in South Korea is expected to reach a valuation of around USD 179 Million by 2033, growing at a CAGR of 8.5% from 2023 to 2033. The market in the country is expected to witness an absolute dollar opportunity of around USD 99 Million.
The rising healthcare expenditure in India has increased growth prospects for the endometrial ablation market in the coming future. As the prevalence of cancer rises in India, so does the demand for various radiation devices and procedures. Furthermore, the government in India is focusing on expanding access to modern and sophisticated healthcare services as well as improving reimbursement coverage. For example, between 2019 and 2020, India's healthcare spending grew from 1.2% to 2.5% of GDP, as the government expanded healthcare spending.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
The market for radiation equipment has advanced significantly during the last decade. These advancements have contributed to the development of more effective, low-cost, and easy-to-use radiotherapy systems that offer enhanced and precise radiation doses, leading to increased tumor-targeting efficiency. With the move from 2D to 3D real-time imaging and planar radiotherapy, dose escalation with improved tumor control and enhanced conformance of radiation to the target growth in the near future, especially in mature markets where technologically advanced products are widely used.
Given these considerations, several market participants started to concentrate their efforts on the development, approval, and marketing of technologically upgraded products. In 2020, PMB, a part of the ALCEN Group, announced the launch of FLASHKNiFE, a FLASH radiation system specialized for clinical studies. In 2020, The Elekta Harmony linear accelerator was launched by Elekta, a system that can treat cancer with a 25% reduction in treatment time and a 30% reduction in footprint.
The goal of such technological improvements is to improve the functionality of radiation delivery systems while also broadening their application area. One of the primary factors driving the growth of the radiotherapy market is the increasing acceptance of these systems in various applications and settings.
In 2020, the hospital category accounted for a significant share due to an increase in the number of patients admitted to hospitals for gynecological issues. In addition, hospitals have advanced treatment devices, which helps in the segment's growth. Furthermore, hospitals experience a significantly higher influx of patients for gynecological treatments than other healthcare settings due to the convenience of handling any difficulties that may arise after surgical operations and the availability of a wide range of treatment alternatives in the facility.
The growth of the ablation technology market for surgical centers, hospitals, and ablation centers is fuelled by the rising prevalence of cancer, sports injuries, and heart problems.
The key players in the global endometrial ablation market are Medtronic, CooperSurgical Inc., Boston Scientific Corp., Ethicon, Inc., Olympus Corp., Richard Wolf GmbH, AngioDynamics, Hologic, Inc., and Minerva Surgical, Inc.
A few of the recent developments in the market are:
In 2023, the worldwide endometrial ablation market value could be around USD 3.4 billion.
The overall market valuation is anticipated to reach nearly USD 6.8 billion by 2033.
The United States leads the global market and could be valued at USD 1.8 billion by 2033 end.
Japan at 9.2% CAGR may drive the regional Market through 2033.
Medtronic, CooperSurgical, and Boston Svientific are some top players in the market.
1. Executive Summary 2. Market Overview 3. Market Risks and Trends Assessment 4. Market Background and Foundation Data Points 5. Key Success Factors 6. Global Market Demand Analysis 2018 to 2022 and Forecast, 2023 to 2033 7. Global Market Value Analysis 2018 to 2022 and Forecast, 2023 to 2033 8. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Type 8.1. Devices 8.1.1. Cryoablation 8.1.2. Radiofrequency Ablation 8.1.3. Hydrothermal Ablation 8.1.4. Thermal Balloon 8.1.5. Microwave Energy 8.2. Procedures 9. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By End-User 9.1. Hospitals 9.2. Clinics 9.3. Ambulatory Surgery Centers 10. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Region 10.1. North America 10.2. Latin America 10.3. Europe 10.4. Asia Pacific 10.5. Middle East and Africa (MEA) 11. North America Market Analysis 2018 to 2022 and Forecast 2023 to 2033 12. Latin America Market Analysis 2018 to 2022 and Forecast 2023 to 2033 13. Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033 14. Asia Pacific Market Analysis 2018 to 2022 and Forecast 2023 to 2033 15. Middle East and Africa Market Analysis 2018 to 2022 and Forecast 2023 to 2033 16. Key Countries Market Analysis 2018 to 2022 and Forecast 2023 to 2033 16.1. Introduction 17. Market Structure Analysis 18. Competition Analysis 18.1. Medtronic 18.2. CooperSurgical Inc. 18.3. Boston Scientific Corp. 18.4. Ethicon Inc. (Johnson & Johnson) 18.5. Olympus Corp. 18.6. AngioDynamics 18.7. Hologic Inc. 18.8. Minerva Surgical 18.9. Richard Wolf GmbH 19. Assumptions and Acronyms Used 20. Research Methodology
Explore Healthcare Insights
View Reports
Endometrial Ablation Market
